About 200 reports

  • Interventional oncology market: Opportunity assessment
  • Key highlights of interventional oncology market

About Interventional Oncology Interventional oncology procedures involve the diagnosis and treatment of cancer and cancer-related problems by using minimally invasive (MI) procedures performed under image guidance. Interventional oncology uses X-ray, ultrasound, computed tomography (CT) or magnetic resonance imaging (MRI) to...

  • Oncology
  • World
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • Terumo Corporation

Oncology Information System Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2022 ##.

  • General Medicine And Specialty Medicine
  • Oncology
  • World
  • Market Shares

VARIAN: PRODUCT PORTFOLIO List of Figures FIGURE ##.

  • General Medicine And Specialty Medicine
  • Oncology
  • APAC
  • World
  • Forecast
  • ONCOLOGY TESTING GLOBAL MARKET REVENUE, BY CANCER TYPE (2016-2024) ($MN)
  • EUROPE ONCOLOGY TESTING MARKET REVENUE, BY APPLICATION AND CANCER CARE (2017) ($MN)

Liquid biopsy is process of obtaining non-solid tissue usually the blood and other body fluids (urine, saliva etc. ) obtained non-invasively as a diagnosis and monitoring tool for disease such as cancer through identification of biomarker in form of cell-fee DNA or circulating tumor cells (CTC) to advance personalized...

  • Oncology
  • World
  • Market Size
  • Biocept, Inc.
  • Guardant Health, Inc.
  • ONCOLOGY
  • 44.3% of the Market Share Comes from Oncology

About Radiofrequency Ablation Radiofrequency ablation devices are used to treat medical conditions such as cancer tumors with the help of imaging techniques such as computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound by using minimally invasive (MI) techniques. This involves the use of high-frequency electromagnetic...

  • Oncology
  • Boston Scientific Corporation
  • Jude Medical, Inc.
  • Medtronic, Inc.
  • Stryker Corporation

It' s the one and only driver of biosimilar usage in the US. " - US key opinion leader Answering key questions about oncology biosimilars Quality of evidence is a hurdle to overcome: What’s worrying KOLs about the evidence available for biosimilars?

  • Biosimilar
  • Oncology
  • Oncology
  • Therapy
  • United States

Oncology application ##. ##. ##.

  • General Medicine And Specialty Medicine
  • Oncology
  • World
  • Forecast
  • Impact of oncology pathways on oncology drug use
  • THE IMPACT OF PATHWAYS ON ONCOLOGY

The costs of treating cancer in the US are spiraling upward, and payers have taken notice. The growing focus on value and quality has driven greater use of clinical pathways: structured, standardized, evidence-based patient management plans that typically favor the most effective, least toxic, and lowest cost treatment options. Providers implement...

  • Health Care Provider
  • Oncology
  • Oncology
  • United States
  • Aetna Inc.
  • IMPACT OF DRIVERS AND CHALLENGES
  • Market drivers

You can easily book an appointment with one online.

  • Oncology
  • AngioDynamics, Inc.
  • Boston Scientific Corporation
  • Ethicon, Inc.
  • Medtronic, Inc.
  • GERMANY
  • SPAIN

According to NCBI, in January 2016, studies conducted by researchers from various universities and hospitals in Germany (Department of Radiation Oncology, University Hospital Erlangen, Department of Radiation Oncology, University Hospital Leipzig, Department of Radiation

  • Hospital
  • Oncology
  • Europe
  • Cianna Medical, Inc.
  • Hologic, Inc.
  • The US Oncology Network - Key Facts
  • The US Oncology Network - SWOT Analysis

The US Oncology Network - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute...

  • Health Services
  • Oncology
  • United States
  • Company
  • McKesson Corporation
  • Surface Oncology Inc, Pharmaceuticals & Healthcare, Deal Details
  • SURFACE ONCOLOGY RAISES USD11.5 MILLION IN PRIVATE PLACEMENT OF SHARES

Summary Surface Oncology Inc (Surface Oncology) is an immuno-oncology company that develops novel antibody therapies for the treatment of cancer.The company’s lead product candidate SRF231 is a human antibody that inhibits the activity of CD47, a protein overexpressed on many types of cancer cells which prevents them from...

  • Oncology
  • Oncology
  • United States
  • Company
  • Novartis AG
  • 21st Century Oncology Inc, Subsidiaries
  • 21ST CENTURY ONCOLOGY ACQUIRES REMAINING 35% STAKE IN SOUTH FLORIDA RADIATION ONCOLOGY

Summary 21st Century Oncology Inc. (21st Century Oncology), a subsidiary of 21st Century Oncology Holdings, Inc., is a provider of integrated cancer care services (ICC). It operates through an integrated network of cancer treatment centers and affiliated physicians with specialization in radiation oncology, breast, gynecological...

  • Oncology
  • Oncology
  • United States
  • Company
  • M&A
  • ZIOPHARM Oncology Inc, Subsidiaries
  • ZIOPHARM Oncology Inc, Subsidiaries

Summary Ziopharm Oncology Inc (Ziopharm), formerly EasyWeb Inc, is a next-generation immune therapies provider.The company offers controlled IL-12 and t-cell therapy. Its next-generation immune therapie platform provides turning cold tumors hot by activating an immune response and non viral genetic modification of...

  • Oncology
  • Therapy
  • United States
  • Company
  • ZIOPHARM Oncology, Inc.
  • 21st Century Oncology Inc, Major Products and Services
  • 21st Century Oncology Inc, Key Employees

21st Century Oncology Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute...

  • Oncology
  • United States
  • Company
  • M&A
  • Elekta Group
  • Surface Oncology Inc, Pharmaceuticals & Healthcare, Deal Details
  • SURFACE ONCOLOGY RAISES USD11.5 MILLION IN PRIVATE PLACEMENT OF SHARES

Summary Surface Oncology Inc (Surface Oncology) is a biopharmaceutical company that develops novel cancer immunotherapies for the treatment of cancer.The company develops treatments in which the immune system can be harnessed to fight cancer. It conducts pre-clinical study through new approaches to enhance the effectiveness...

  • Oncology
  • Oncology
  • United States
  • Company
  • Novartis AG

ONE UNIT REFERS TO ONE SPECIALTY BED.

  • Oncology
  • East Asia
  • Japan
  • Forecast
  • Market Size

Lumpectomy Market Analysis by End User ##. ## Hospitals ##. ## Oncology Research & Screening Centers ##.

  • Breast Cancer
  • General Medicine And Specialty Medicine
  • Oncology
  • United States
  • IX: MEDICAL ONCOLOGY PENETRATION BY GEOGRAPHY
  • XVI: GYNECOLOGICAL ONCOLOGY MEAL FREQUENCY

Summary Pharmaceutical sales and marketing organizations face a challenging U.S. environment as physician access becomes increasingly restricted. Despite this major hurdle, personal promotion remains one of the most effective sales and marketing tools and it has never been more critical for drug and device makers to actively...

  • Health Care Provider
  • Healthcare
  • Oncology
  • Therapy
  • United States
  • X: MEDICAL ONCOLOGY MEAL FREQUENCY
  • VIII: HEMATOLOGY/ONCOLOGY MEAL FREQUENCY

Summary Pharmaceutical sales and marketing organizations face a challenging U.S. environment as physician access becomes increasingly restricted. Despite this major hurdle, personal promotion remains one of the most effective sales and marketing tools and it has never been more critical for drug and device makers to actively...

  • Health Care Provider
  • Healthcare
  • Oncology
  • Therapy
  • United States
  • IX: GYNECOLOGICAL ONCOLOGY PENETRATION BY GEOGRAPHY
  • X: GYNECOLOGICAL ONCOLOGY MEAL FREQUENCY

Summary Pharmaceutical sales and marketing organizations face a challenging U.S. environment as physician access becomes increasingly restricted. Despite this major hurdle, personal promotion remains one of the most effective sales and marketing tools and it has never been more critical for drug and device makers to actively...

  • Health Care Provider
  • Healthcare
  • Oncology
  • Therapy
  • United States
  • VIII: HEMATOLOGY/ONCOLOGY MEAL FREQUENCY
  • XIV: GYNECOLOGICAL ONCOLOGY MEAL FREQUENCY

Summary Pharmaceutical sales and marketing organizations face a challenging U.S. environment as physician access becomes increasingly restricted. Despite this major hurdle, personal promotion remains one of the most effective sales and marketing tools and it has never been more critical for drug and device makers to actively...

  • Health Care Provider
  • Healthcare
  • Oncology
  • Therapy
  • United States
  • VIII: HEMATOLOGY/ONCOLOGY MEAL FREQUENCY
  • XIII: SURGICAL ONCOLOGY PENETRATION BY GEOGRAPHY

Summary Pharmaceutical sales and marketing organizations face a challenging U.S. environment as physician access becomes increasingly restricted. Despite this major hurdle, personal promotion remains one of the most effective sales and marketing tools and it has never been more critical for drug and device makers to actively...

  • Health Care Provider
  • Healthcare
  • Oncology
  • Therapy
  • United States
  • IX: MEDICAL ONCOLOGY PENETRATION BY GEOGRAPHY
  • VIII: HEMATOLOGY/ONCOLOGY MEAL FREQUENCY

Summary Pharmaceutical sales and marketing organizations face a challenging U.S. environment as physician access becomes increasingly restricted. Despite this major hurdle, personal promotion remains one of the most effective sales and marketing tools and it has never been more critical for drug and device makers to actively...

  • Health Care Provider
  • Healthcare
  • Oncology
  • Therapy
  • United States
  • XIV: RADIATION ONCOLOGY MEAL FREQUENCY
  • VIII: HEMATOLOGY/ONCOLOGY MEAL FREQUENCY

Summary Pharmaceutical sales and marketing organizations face a challenging U.S. environment as physician access becomes increasingly restricted. Despite this major hurdle, personal promotion remains one of the most effective sales and marketing tools and it has never been more critical for drug and device makers to actively...

  • Health Care Provider
  • Healthcare
  • Oncology
  • Therapy
  • United States
  • VIII: HEMATOLOGY/ONCOLOGY MEAL FREQUENCY
  • XIV: RADIATION ONCOLOGY MEAL FREQUENCY

Summary Pharmaceutical sales and marketing organizations face a challenging U.S. environment as physician access becomes increasingly restricted. Despite this major hurdle, personal promotion remains one of the most effective sales and marketing tools and it has never been more critical for drug and device makers to actively...

  • Health Care Provider
  • Healthcare
  • Oncology
  • Therapy
  • United States

Hematology/ Oncology, Gynecologic Oncology, Medical Oncology, Internal Medicine, Obstetrics/ Gynecology, and Radiation Oncology) and how does this compare to its peers and the overall set of rep-accessible physicians?

  • General Medicine And Specialty Medicine
  • Oncology
  • United States

Hematology/ Oncology, Gynecologic Oncology, Medical Oncology, Obstetrics/ Gynecology, Internal Medicine, and Radiation Oncology) and how does this compare to its peers and the overall set of rep-accessible physicians?

  • General Medicine And Specialty Medicine
  • Oncology
  • United States

Hematology/ Oncology, Medical Oncology, Gynecologic Oncology, Internal Medicine, and Radiation Oncology) and how does this compare to its peers and the overall set of rep-accessible physicians?

  • General Medicine And Specialty Medicine
  • Oncology
  • United States

Hematology/ Oncology, Medical Oncology, Gynecologic Oncology, Radiation Oncology, and Internal Medicine) and how does this compare to its peers and the overall set of rep-accessible physicians?

  • General Medicine And Specialty Medicine
  • Oncology
  • United States